146 results on '"Wen, Jing-Yun"'
Search Results
2. The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy
3. An overview of mouse models of hepatocellular carcinoma
4. PPM1G promotes cell proliferation via modulating mutant GOF p53 protein expression in hepatocellular carcinoma
5. Brain magnetic resonance imaging predictors in anti‐N‐methyl‐D‐aspartate receptor encephalitis
6. Research progress in preparation and application of hemicellulose-based hydrogels
7. Research progress in preparation and application of hemicellulose-based hydrogels
8. NMR and ESI–MS spectrometry characterization of autohydrolysis xylo-oligosaccharides separated by gel permeation chromatography
9. Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma
10. The facilitating effects of KRT80 on chemoresistance, lipogenesis, and invasion of esophageal cancer.
11. CD45− erythroid progenitor cells promote lymph node metastasis in gastric cancer by inducing a hybrid epithelial/mesenchymal state in lymphatic endothelial cells.
12. The potential oncogenic effect of tissue-specific expression of JC polyoma T antigen in digestive epithelial cells
13. A comparison of dioctahedral smectite and iodine glycerin cream with topical mouth rinse in treatment of chemotherapy induced oral mucositis: A pilot study
14. Corrigendum to “ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3 [Cancer Letters 535 (2022) 215646]’’
15. ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3
16. The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy
17. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma
18. EBV-Induced CXCL8 Upregulation Promotes Vasculogenic Mimicry in Gastric Carcinoma via NF-κB Signaling
19. Hypoxia-induced ebv-circLMP2A promotes angiogenesis in EBV-associated gastric carcinoma through the KHSRP/VHL/HIF1α/VEGFA pathway
20. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma
21. Prognosis value of mitotic kinase Aurora-A for primary duodenal adenocarcinoma
22. Anti-freezing, water-retaining, conductive, and strain-sensitive hemicellulose/polypyrrole composite hydrogels for flexible sensors
23. ebv-circRPMS1 Promotes the Progression of EBV-Associated Gastric Carcinoma via Sam68 Complex Dependent Activation of METTL3
24. An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study
25. Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer
26. Examination of artificial MiRNA mimics with centered-site complementarity for gene targeting.
27. Prognostic and immunological role of CD36: A pan-cancer analysis
28. Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis
29. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials
30. The Association of Incidence of Face-Touching Behaviors with Masks Wearing Rates During the Coronavirus Disease 2019 Pandemic
31. Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer
32. The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments
33. Modified CLIP score with albumin-bilirubin grade in relation to prognostic value in HBV-related hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization therapy.
34. Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy
35. The Predictive Value of Albumin-to-Alkaline Phosphatase Ratio for Overall Survival of Hepatocellular Carcinoma Patients Treated with Trans-Catheter Arterial Chemoembolization Therapy
36. Comparison of five staging systems in predicting the survival rate of patients with hepatocellular carcinoma undergoing trans‑arterial chemoembolization therapy
37. Serum Golgi protein 73 is a prognostic rather than diagnostic marker in hepatocellular carcinoma
38. Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma
39. Validation and ranking of seven staging systems of hepatocellular carcinoma
40. Stat3-siRNA inhibits the growth of gastric cancer in vitro and in vivo
41. Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial Chemoembolization
42. Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma
43. Examination of Artificial MiRNA Mimics with Centered–Site Complementarity for Gene Targeting
44. Comparison of five staging systems in predicting the survival rate of patients with hepatocellular carcinoma undergoing trans-arterial chemoembolization therapy.
45. Staged Improvement in Awareness of Disease for Elderly Cancer Patients in Southern China
46. Alanine aminotransferase to hemoglobin ratio is an indicator for disease progression for hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization
47. MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells
48. Clinicopathological features and prognostic analysis of extragastrointestinal stromal tumor in an Asian center.
49. Hepatitis B Virus DNA Negativity Acts as a Favorable Prognostic Factor in Hepatocellular Carcinoma Patients
50. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.